T1	intervention 11 30	hydrochlorothiazide
T2	condition 34 49	drainage volume
T3	condition 54 70	seroma formation
T4	No-of-participants 783 788	Sixty
T5	eligibility 789 894	patients with breast cancer who underwent skin- or nipple-sparing mastectomy and DIEP flap reconstruction
T6	duration 909 942	between August 2016 and June 2017
T7	control 1101 1122	no diuretic (control)
T8	outcome-Measure 1128 1199	clinicopathological characteristics, drainage time, and drainage volume
T9	outcome 1256 1303	average total drainage volume at the donor site
T10	outcome 1387 1433	differences in body mass index and flap weight
T11	outcome 1533 1572	No hypotension or electrolyte imbalance
